The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 22, 2023

Filed:

Oct. 29, 2020
Applicants:

Optoceutics Aps, Kongens Lyngby, DK;

Technical University of Denmark, Kgs. Lyngby, DK;

Inventors:

Marcus Carstensen, Frederiksberg, DK;

Paul Michael Petersen, Hillerod, DK;

Jes Broeng, Birkerod, DK;

Mark Henney, Copenhagen, DK;

Ngoc Mai Nguyen, San Jose, CA (US);

Robert Dobkin, Monte Sereno, CA (US);

Assignee:

Optoceutics ApS, Copenhagen, DK;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61M 21/02 (2006.01); G16H 20/40 (2018.01); G16H 40/67 (2018.01); G16H 20/70 (2018.01); G16H 10/60 (2018.01); A61B 3/11 (2006.01); A61B 3/113 (2006.01); A61B 3/14 (2006.01); A61M 21/00 (2006.01);
U.S. Cl.
CPC ...
A61M 21/02 (2013.01); G16H 20/40 (2018.01); G16H 20/70 (2018.01); G16H 40/67 (2018.01); A61B 3/112 (2013.01); A61B 3/113 (2013.01); A61B 3/14 (2013.01); A61M 2021/0044 (2013.01); A61M 2205/3303 (2013.01); A61M 2205/583 (2013.01); G16H 10/60 (2018.01);
Abstract

Gamma brain stimulation for preventing or treating Alzheimer's disease or sleeping disorders using light or sound is known. A strobing 40 Hz light source has been shown to cause positive effects due to the stimulation. It is an advantage to know the actual dosage of light that enters the person's eyes in order to understand the relationship between dosage and effectiveness. A camera is used to detect the subject's gaze angle, distance, pupil diameter and any other factors that affect the light power that enters the eye. A target dosage is first determined by a medical worker, such as to determine the effects of the exact same dosage on a group of similar persons, such as Alzheimer's patients. With deviations of gaze angle, distance, and pupil size from the ideal, the effective dosage is decreased. The disclosed system adjusts the actual dosage, such as session duration, based on such factors so that the final dosage received by the person is consistent and meets the target dosage.


Find Patent Forward Citations

Loading…